Semergal
Pfizer (United States)
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Pfizer (United States) (2)
2021
-
Cost and burden of poor anticoagulation control with vitamin K antagonists in patients with nonvalvular atrial fibrillation in Spain
Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 773-780
2019
-
ICUSI questionnaire validation. Quality of anticoagulation in patients with atrial fibrillation treated with vitamin K antagonists
REC: CardioClinics, Vol. 54, Núm. 3, pp. 165-172